Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a

Meng, Linyan, Person, Richard E., Beaudet, Arthur L.·2012·Human Molecular Genetics
DOI 10.1093/hmg/dds130

Cited by (202)

Items 101–200 of 202

  1. Antisense oligonucleotides as a precision therapy for developmental and epileptic encephalopathies
    Paloma García Quilón, Greta Volpedo, Serena Cappato, Loretta Ferrera, Federico Zara, Renata Bocciardi, Antonella Riva, Pasquale Striano · 2024 · CNS Neuroscience & Therapeutics
  2. Screening individuals with intellectual disability, autism and Tourette's syndrome for KCNK9 mutations and aberrant DNA methylation within the 8q24 imprinted cluster.
    Marta Sánchez-Delgado, Cristina Camprubí, Zeynep Tümer, Francisco Martı́nez, Montserrat Milà, David Monk · 2014 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  3. Non-coding RNAs in chromatin disease involving neurological defects
    Floriana Della Ragione, Miriam Gagliardi, Maurizio D’Esposito, Maria Rosaria Matarazzo · 2014 · Frontiers in Cellular Neuroscience
  4. Genomic imprinting does not reduce the dosage of UBE3A in neurons
    Paul Hillman, Sarah Christian, Ryan N. Doan, Noah D. Cohen, Kranti Konganti, Kory C. Douglas, Xu Wang, Paul B. Samollow, Scott V. Dindot · 2017 · Epigenetics & Chromatin
  5. Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader–Willi syndrome
    Shi‐Bing Wong, Tzong‐Shi Wang, Wen‐Hsin Tsai, Li‐Ping Tsai · 2019 · Tzu Chi Medical Journal
  6. Cerebral organoids as an in vitro model to study autism spectrum disorders
    Alexa Rabeling, Mubeen Goolam · 2022 · Gene Therapy
  7. Gene therapy for Angelman Syndrome: Contemporary approaches and future endeavors.
    C. Tsagkaris, Vasiliki Papakosta, A. Miranda, Lefkothea Zacharopoulou, V. Danilchenko, L. Matiashova, A. Dhar · 2020 · Current Gene Therapy
  8. Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep
    Yuval Levin, Nishitha S. Hosamane, Taylor E. McNair, Shrujana S. Kunnam, Benjamin D. Philpot, Zheng Fan, Michael S. Sidorov · 2022 · Autism Research
  9. Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome
    Joseph C. Krzeski, Matthew C. Judson, Benjamin D. Philpot · 2024 · Current Opinion in Neurobiology
  10. Localization is the key to action: regulatory peculiarities of lncRNAs
    Joice de Faria Poloni, Fábio Henrique Schuster de Oliveira, Bruno César Feltes · 2024 · Frontiers in Genetics
  11. Antisense Activity across the Nesp Promoter is Required for Nespas-Mediated Silencing in the Imprinted Gnas Cluster
    Charlotte Tibbit, Christine M. Williamson, Stuti Mehta, Simon Ball, Mita Chotalia, Wade T. Nottingham, Sally A. Eaton, Mohamed Mohideen Quwailid, Lydia Teboul, Gavin Kelsey et al. · 2015 · Non-Coding RNA
  12. Epigenetics of Circadian Rhythms in Imprinted Neurodevelopmental Disorders
    Rochelle L. Coulson, Janine M. LaSalle · 2018 · Progress in molecular biology and translational science
  13. Towards an understanding of Angelman syndrome in mice studies
    Xin Yang · 2019 · Journal of Neuroscience Research
  14. Publisher's note
    Sylvie Tordjman, David Cohen, Nathalie Coulon, George M. Anderson, Michel Botbol, Roberto Canitano, Pierre L. Roubertoux · 2017 · Neuroscience & Biobehavioral Reviews
  15. Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
    Linn Amanda Syding, Agnieszka Kubik‐Zahorodna, Petr Nickl, Vendula Novosadová, Jana Kopkanova, Petr Kašpárek, Jan Procházka, Radislav Sedláček · 2022 · Cells
  16. Non-Coding RNAs at the Gnas and Snrpn-Ube3a Imprinted Gene Loci and Their Involvement in Hereditary Disorders
    Antonius Plagge · 2012 · Frontiers in Genetics
  17. Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation
    Mohamed A. El-Brolosy, A. Oak, Ho-Ang An, Yassine Damergi, André Fischer, R. Saunders, Jing-Chuan Luo, Amer Balabaki, J. Guez, Troy W. Whitfield et al. · 2026 · Science
  18. Regional and cellular organization of the autism-associated protein UBE3A/E6AP and its antisense transcript in the brain of the developing rhesus monkey
    Chavely Gonzalez Ramirez, Sarah G. Salvador, Ridthi Kartik Rekha Patel, Sarah Clark, Noah W. Miller, Lucas M. James, Nicholas W. Ringelberg, Jeremy M. Simon, Jeffrey Bennett, David G. Amaral et al. · 2024 · Frontiers in Neuroanatomy
  19. Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A -ATS with long-lasting effect in monkeys
    Ravi Jagasia, Charlotte Bon, Soren V Rasmussen, Solveig Badillo, Disa Tehler, Danièle Buchy, Marco Berrera, Megana K. Prasad, Stormy J. Chamberlain, Marco Terrigno et al. · 2025 · Nucleic Acids Research
  20. Epigenetics in rare neurological diseases
    Chris-Tiann Roberts, Khatereh Saei Arezoumand, Ashraf Kadar Shahib, James Davie, Mojgan Rastegar · 2024 · Frontiers in Cell and Developmental Biology
  21. Promising therapeutic aspects in human genetic imprinting disorders
    Yunqi Chao, Yifang Qin, Xinyi Zou, Xiangzhi Wang, Chenxi Hu, Fangling Xia, Chaochun Zou · 2022 · Clinical Epigenetics
  22. Association of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the DPYD enigma
    Lukrecija Brečević, Martina Rinčić, Željka Krsnik, Goran Sedmak, Ahmed Basheer Hamid, Nadezda Kosyakova, Ivan Galić, Thomas Liehr, Fran Borovečki · 2015 · Translational Neuroscience
  23. LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review
    Shayan Khalilollah, Sina Kalantari Soltanieh, Raed Obaid Saleh, Abdullah Ali Alzahrani, Hatem Ghaleb Maabreh, Mais Mazin Al‐Hamdani, Mahmoud Dehghani-Ghorbi, Metanat Shafiei Khonachaei, Reza Akhavan‐Sigari · 2024 · Cytokine
  24. Imprinted silencing is extended over broad chromosomal domains in mouse extra-embryonic lineages
    Tomasz M. Kuliński, Denise P. Barlow, Quanah James Hudson · 2013 · Current Opinion in Cell Biology
  25. Joining forces to develop individualized antisense oligonucleotides for patients with brain or eye diseases: the example of the Dutch Center for RNA Therapeutics
    Annemieke M Aartsma-Rus, Rob W.J. Collin, Ype Elgersma, Marlen C. Lauffer, Willeke van Roon‐Mom · 2024 · Therapeutic Advances in Rare Disease
  26. Genome-wide methylation analysis of retrocopy-associated CpG islands and their genomic environment
    Katrin Grothaus, Deniz Kanber, Alexandra Gellhaus, Barbara Mikat, Julia Kolarova, Reiner Siebert, Dagmar Wieczorek, Bernhard Horsthemke · 2016 · Epigenetics
  27. Clinical manifestations of Angelman syndrome in children
    Горчханова Зарета Казбулатовна, Ekaterina Alexandrovna Nikolaeva, Боченков Сергей Викторович, Е. Д. Белоусова · 2022 · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
  28. Lack of UBE3A-Mediated Regulation of Synaptic SK2 Channels Contributes to Learning and Memory Impairment in the Female Mouse Model of Angelman Syndrome
    Jiandong Sun, Yan Liu, Xiaoning Hao, Michel Baudry, Xiaoning Bi · 2022 · Neural Plasticity
  29. Contextual fear memory impairment in Angelman syndrome model mice is associated with altered transcriptional responses
    Wenyue Su, Yan Liu, Aileen J. Lam, Xiaoning Hao, Michel Baudry, Xiaoning Bi · 2023 · Scientific Reports
  30. Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome
    Maria N. Schultz, Jacqueline N. Crawley · 2020 · Learning & Memory
  31. Stem cell models of Angelman syndrome
    João Camões dos Santos, Carolina Appleton, Francisca Cazaux Mateus, Rita Covas, Evguenia Bekman, Simão Teixeira da Rocha · 2023 · Frontiers in Cell and Developmental Biology
  32. The role of glia in the dysregulation of neuronal spinogenesis in Ube3a-dependent ASD
    Zachary Gardner, Otto Holbrook, Yuan Tian, KathrynAnn E. Odamah, Heng‐Ye Man · 2024 · Experimental Neurology
  33. Multiscale spatio-temporal dynamics of UBE3A gene in brain physiology and neurodevelopmental disorders
    Martina Biagioni, Federica Baronchelli, Matteo Fossati · 2024 · Neurobiology of Disease
  34. IPSC Models of Chromosome 15Q Imprinting Disorders: From Disease Modeling to Therapeutic Strategies
    Noélle D. Germain, Eric S. Levine, Stormy J. Chamberlain · 2020 · Advances in neurobiology
  35. Neurodevelopmental Underpinnings of Angelman Syndrome
    Guohui Li · 2014 · Journal of Bioanalysis & Biomedicine
  36. UBE3A reinstatement restores behaviorand proteome in an Angelman syndrome mouse model of imprinting defects
    Claudia Milazzo, Ramanathan Narayanan, Solveig Badillo, Silvia Wang, Rosaisela Almand, Roos Monshouwer, Manuel Tzouros, Sabrina Golling, Edwin Mientjes, Stormy J. Chamberlain et al. · 2025 · Molecular Autism
  37. Imprinted expression in cystic embryoid bodies shows an embryonic and not an extra-embryonic pattern
    Tomasz M. Kuliński, M Rita Taba Casari, Philipp M. Guenzl, Daniel Wenzel, Daniel Andergassen, Anastasiya Hladik, Paul Datlinger, Matthias Farlik, Hans‐Christian Theussl, Josef Martin Penninger et al. · 2015 · Developmental Biology
  38. Antisense oligonucleotides targeting UBE3A-ATS restore expression of UBE3A by relieving transcriptional interference
    Noélle D. Germain, Dea Gorka, Ryan Drennan, Paymaan Jafar‐Nejad, Amanda J. Whipple, Leighton J. Core, Eric S. Levine, Frank Rigo, Stormy J. Chamberlain · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Angelman syndrome patient neuron screen identifies a potent and selective clinical ASO targeting UBE3A-ATS with long lasting effect in cynomolgus monkey
    Ravi Jagasia, Charlotte Bon, Soren V. Rasmussen, Solveig Badillo, Disa Tehler, Danièle Buchy, Marco Berrera, Megana K. Prasad, Marco Terrigno, Nikhil Janak Pandya et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  40. A role for chromatin topology in imprinted domain regulation
    William A. MacDonald, Saqib S. Sachani, Carlee R. White, Mellissa R.W. Mann · 2015 · Biochemistry and Cell Biology
  41. Epigenetics in intellectual disability
    Taryn E. Jakub, Katerine Quesnel, Crystal Keung, Nathalie G. Bérubé, Jamie M. Kramer · 2021 · Elsevier eBooks
  42. Monoallelic, antisense and total RNA transcription in an in vitro neural differentiation system based on F1 hybrid mice
    Shinji Kondo, Hidemasa Kato, Yutaka Suzuki, Toyoyuki Takada, Masamitsu Eitoku, Toshihiko Shiroishi, Narufumi Suganuma, Sumio Sugano, Hidenori Kiyosawa · 2019 · Journal of Cell Science
  43. ` Neurodevelopmental Underpinnings of Angelman Syndrome
    Guohui Li Shenfeng Qiu · 2014 · OMICS Journal of Radiology
  44. Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists
    Debopam Samanta · 2026 · Brain and Development
  45. Dietary Intake of Octanoic Acid Restores UBE3A Expression and Improves the Behavioral Phenotypes in a Mouse Model of Angelman Syndrome
    Song Qu, Xingying Guan, Hongyan Li, Jian Yang, Pu Sun, Cui Song, Natalia Surzenko, Yanyan Wang · 2025 · The FASEB Journal
  46. From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
    F. Isabella Zampeta, Ben Distel, Ype Elgersma, Rik Iping · 2022 · Human Genetics
  47. A Catalogue of Putative cis-Regulatory Interactions Between Long Non-coding RNAs and Proximal Coding Genes Based on Correlative Analysis Across Diverse Human Tumors
    Swaraj Basu, Erik Larsson · 2018 · G3 Genes Genomes Genetics
  48. ANGELMAN SYNDROME
    Charles A. Williams, Jennifer M. Mathews · 2020
  49. The essential role of E3 ubiquitin ligases in the pathogenesis of neurodevelopmental and psychiatric disorders: Cul3, Cul4, Ube3a, and ZNRF1
    Moeka Ohno, Shuji Wakatsuki, Toshiyuki Araki · 2025 · Biochemical and Biophysical Research Communications
  50. Atypical alpha oscillatory EEG dynamics in children with Angelman syndrome
    Abigail H. Dickinson, Marjorie Sapphire Bowen-Kauth, Jeremy J Shide, Anna E Youngkin, Nishitha S. Hosamane, Courtney A McNair, Declan P Ryan, Catherine J. Chu, Michael S. Sidorov · 2025 · NeuroImage Clinical
  51. UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes
    Kevin R. Nash, Umesh K. Jinwal, Krishna Moorthi Bhat · 2024 · Journal of Alzheimer s Disease
  52. Light activates Ube3a, an Angelman syndrome‐associated gene, by mediating the chromatin structures during postnatal development of mouse retina
    Chao‐Wen Lin, Yi‐Chun Cheng, Chang‐Hao Yang, Hsien‐Sung Huang · 2023 · Journal of Neurochemistry
  53. Integration of CTCF loops, methylome, and transcriptome in differentiating LUHMES as a model for imprinting dynamics of the 15q11-q13 locus in human neurons
    Orangel J. Gutierrez Fugón, Osman Sharifi, Nicholas G. Heath, Daniela C. Soto, J. Antonio Gomez, Dag H. Yasui, Aron Judd P. Mendiola, Henriette O’Geen, Ulrika Beitnere, Markéta Tomková et al. · 2024 · Human Molecular Genetics
  54. Comparison of two types of non-adherent plate for neuronal differentiation of mouse embryonic stem cells
    Masamitsu Eitoku, Narufumi Suganuma, Hidenori Kiyosawa · 2016 · Cytotechnology
  55. Crossing the finish line towards a disease-modifying treatment for Angelman syndrome
    Matthew C. Judson, Luís Pereira de Almeida, Rebecca D. Burdine, Stormy J. Chamberlain, Benjamin E. Deverman, Ben Distel, Michael Ehlers, Elizabeth Jalazo, Steven A. Kushner, Mark Nespeca et al. · 2026 · Journal of Neurodevelopmental Disorders
  56. Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression
    Isabella Trew, Steve Donald Wilton, Jessica M. Cale, May Thandar Aung-Htut · 2026 · Molecular Therapy — Nucleic Acids
  57. Imprinting analysis by droplet digital PCR coupled with locked nucleic acid TaqMan probes
    Maiko Mitake, Shiori Hirano, Tatsuya Kishino · 2020 · Epigenetics
  58. Developmental disabilities, autism, and schizophrenia at a single locus
    Lawrence T. Reiter · 2020 · Elsevier eBooks
  59. Angelman syndrome
    Jennifer M. Mathews, Emily K. Cook, Seth S. Margolis, Charles A. Williams · 2020 · Elsevier eBooks
  60. Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications
    Cecilia Pandini, Federica Rey, Cristina Cereda, Stephana Carelli, Paolo Gandellini · 2023 · Pharmaceuticals
  61. Prader–Willi and Angelman syndromes
    Emily Y. Smith, James L. Resnick · 2014 · Cambridge University Press eBooks
  62. Epigenetics in Intellectual Disability
    Nathalie G. Bérubé, Jamie M. Kramer · 2014 · Elsevier eBooks
  63. Basic Epigenetic Mechanisms and Phenomena
    Melanie R. Hassler, Elisa Redl, Quanah James Hudson, Wolfgang J. Miller, Gerda Egger · 2016 · Elsevier eBooks
  64. Courtship and distress ultrasonic vocalizations are altered in a mouse model of Angelman syndrome
    Caleigh D. Guoynes, Grace Pavalko, Michael S. Sidorov · 2025 · Journal of Neurodevelopmental Disorders
  65. RNAi-Induced Expression of Paternal UBE3A
    Hye Ri Kang, Violeta Zaric, Volodymyr Rybalchenko, Steven J. Gray, Ryan K. Butler · 2026 · Genes
  66. UBE3A isoform-selective and non-selective contributions to Angelman syndrome phenotypes
    Joseph C. Krzeski, Edwin Mientjes, Matthew C. Judson, Guangkuo Dong, Rebecca I. Hipp, Katelyn H. Lien, Bin Gu, Benjamin D. Philpot, Ype Elgersma · 2026 · Molecular Psychiatry
  67. A xenotransplantation model for reactivation of paternal UBE3A using human-specific antisense oligonucleotides
    Hilde Smeenk, Bas Lendemeijer, Mirle G. Buurma, Michell A. Forgione, Denise E. Slump, Roos Monshouwer, Ilse Wallaard, Edwin Mientjes, Witte J.G. Hoogendijk, Ype Elgersma et al. · 2026 · Scientific Reports
  68. Emerging Therapies for Angelman Syndrome
    Cyril Tychon, Theodora Markati, Serpil Alkan, Laura Vanden Brande, Laurent Servais · 2026 · CNS Drugs
  69. UBE3A Dosage Imbalance as a Molecular Framework Linking Angelman Syndrome and Dup15q‐Associated Autism Phenotypes
    Ruslan Kurmashev · 2026 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  70. Long Noncoding RNA in Epigenetic Gene Regulation
    Yuko Hasegawa, Shinichi Nakagawa · 2015 · Springer eBooks
  71. Roles of Long Non-coding RNAs in Genomic Imprinting
    Kristen Martins‐Taylor, Stormy J. Chamberlain · 2013 · Springer eBooks
  72. The Function of Ubiquitin Protein Ligase E3A and its Roles in Human Diseases
    Xiaofang Zhou, Naser Jafari, Shishan Deng, Cai Huang · 2015 · Journal of Biochemistry and Molecular Biology Research
  73. Angelman Syndrome
    Charles A. Williams, Jennifer M. Mueller · 2014 · Elsevier eBooks
  74. Fetal Epigenetic Origins of Disease
    Melissa Suter, Kjersti Marie Aagaard · 2014 · Elsevier eBooks
  75. Molecular Genetic Findings in Prader-Willi Syndrome
    Stefan Stamm, Merlin G. Butler · 2022 · Springer eBooks
  76. UBE3A reinstatement restores behavior and proteome in an Angelman Syndrome mouse model of Imprinting Defects
    Claudia Milazzo, Ramanathan Narayanan, Solveig Badillo, Silvia Wang, Rosaisela Almand, Edwin Mientjes, Stormy J. Chamberlain, Thomas Kremer, Ype Elgersma · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman Syndrome
    Xiaona Lu, Ying Xie, Youmei Bao, Jiang Yu, Zefeng Wang, Jiali Fan, Wendy C. Sheu, Gretchen Long, Zewei Tu, Jie Tong et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Ube3a Role in Synaptic Plasticity and Neurodevelopmental Disorders.The Lessons from Angelman Syndrome.
    Irina Filonova · 2014 · Digital Commons - University of South Florida (University of South Florida)
  79. Social dysfunction and mental retardation
    Susanna Pietropaolo, Frans Sluyter, Wim E. Crusio · 2014 · Cambridge University Press eBooks
  80. Identifying the role of the imprinted gene Pw1/Peg3 in the central nervous system
    Anne-Lyse Denizot · 2015 · HAL
  81. Controle epigenético do gene imprinted SNRPN durante o desenvolvimento e reprogramação nuclear em equídeos
    Náthia Nathaly Rigoglio · 2016 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  82. Estudo da expressão diferencial de genes localizados no segmento cromossômico 15q11-q13 em pacientes com as síndromes de Angelman e Prader-Willi
    Estela Mitie Cruvinel · 2015 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  83. Molecular characterization of a congenital overgrowth syndrome induced by assisted reproduction
    Zhiyuan Chen · 2017
  84. Синдром Ангельмана. Часть 1 (этиология и патогенез)
    А.Е. Абатуров, L.L. Petrenko, Ye.L. Krivusha · 2020 · CHILD`S HEALTH
  85. Diagnosis of Neurogenetic Disorders: Contribution of Next Generation Sequencing and Deep Phenotyping
    Alisdair McNeill · 2019 · MDPI eBooks
  86. Clinical manifestations of Angelman syndrome
    Курмаева Елена Анатольевна, S. Ya. Volgina, Nailya A. Solovyeva, Galina A. Kulakova · 2022 · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
  87. CRISPR technology and its potential role in treating rare imprinting diseases
    Petr Nickl, Linn Amanda Syding, Radislav Sedláček · 2023 · Principles of Gender-Specific Medicine
  88. Emerging concepts involving inhibitory and activating RNA functionalization towards the understanding of microcephaly phenotypes and brain diseases in humans
    Mayuri Tokunaga, Takuya Imamura · 2023 · Frontiers in Cell and Developmental Biology
  89. Therapeutic approaches to imprinting diseases
    Hela Sassi, Léa Guerrini‐Rousseau, Jacques Grill, Étienne Rouleau · 2023 · Elsevier eBooks
  90. Targeted Augmentation of Nuclear Gene Output (TANGO)
    Lori L. Isom, Kelly G. Knupp · 2024 · Oxford University Press eBooks
  91. Use of Basket Trials to Solve Sleep Problems in Patients with Rare Diseases
    Lara C. Pullen, Nick Bott, Cate McCanless, Amee Revana, Günes Sevinc, Casey Gorman, Alexandra Duncan, Sarah Poliquin, Anna C. Pfalzer, Katie Q. Schmidt et al. · 2024 · Clocks & Sleep
  92. Perinatal Lead (Pb) Exposure Increases Mouse Embryonic Weight and Alters Neuronal Gene Expression
    Bambarendage P. U. Perera, Minghua Li, Anagha Tapaswi, Junru Pan, Dongyue Wang, Tejas Goswami, Rachel K. Morgan, Kelly M. Bakulski, Jaclyn M. Goodrich, Maureen A. Sartor et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Genomic imprinting disorders in the structure of syndromic obesity in children
    Olga V. Vasyukova, Е. П. Атавина-Ермакова, E. G. Panchenko, Daria A. Kopytina, Olga A. Simonova, Vasilisa Udalova, Ilya V. Kanivets, Daria Akimova, Mikhail Y. Skoblov, M. A. Andreeva et al. · 2025 · Obesity and metabolism
  94. Epigenetic Therapies in Neurological Diseases
    Hsien‐Sung Huang, Benjamin D. Philpot, Yong‐hui Jiang · 2013 · Epigenetics and human health
  95. The serotonin receptor 7 as an emerging target to restore altered neuroplasticity in Angelman syndrome
    Eduardo Penna, Amelia Pizzella, Natalia Abate, Noemi Conte, Fabiano Cimmino, Maria Pina Mollica, Rossella Di Giaimo, Michel Baudry, Xiaoning Bi, Marianna Crispino · 2026 · Experimental Neurology
  96. Vers l'identification des facteurs impliqués dans la régulation concertée des gènes soumis à empreinte dans le cerveau
    Jil Cercy · 2019
  97. Bridging development and disease: the potential of LncRNAs as biomarkers and therapeutics in pediatric neurological disorders
    Ahmed M. Kabel, Ahmed A. AlBarraq · 2026 · Pediatric Research
  98. Toward a Small Molecule Therapy for Angelman Syndrome: Structure–Activity Relationship Studies of 3-Aminopyrazole Phenylacetamides as Paternal Ube3a Unsilencers
    Anna Welton-Arndt, Hannah C. Nourie, Hanna Vihma, Siyuan Liang, Jonathan Super, Kelin Li, Jon L. Collins, Hsueh-Cheng Huang, Allison Zhang, Ashley E Trojniak et al. · 2026 · Journal of Medicinal Chemistry
  99. SMCHD1 is a novel target for gene-activation therapy to treat Prader-Willi Syndrome
    Megan Iminitoff, Anna K. Le Fevre, Tamara Cameron, Hannah Kate Vanyai, Caleb Chew, Sarah Kinkel, Kelsey A. Breslin, Susanne Theiß, Quentin A. Gouil, Merlin C. Thomas et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  100. RNA-Based Therapeutics in Genetic Neurodevelopmental Disorders: Bridging Molecular Genetics and Precision Medicine
    Ina Ofelia Focșa, Catrinel Iliescu, Cristina Pomeran, Magdalena Budișteanu, Carmen Sandu, Alice Denisa Dică, Florentina Ionela Lincă, Cristina Moțoiescu, Diana Bârcă, Ioana Minciu et al. · 2026 · International Journal of Molecular Sciences